Senators urge stem cell expansion

Letter to the president cites recent research making new uncontaminated lines possible.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Citing recent research advances, Sen. Arlen Specter (R-Penn.) and other senators are urging President Bush to expand eligibility requirements for federal funding of human embryonic stem cells (HESC).

"With the discovery of a way to grow human stem cells without mouse cells, it is possible to use new stem cell lines that have never been exposed to mouse cells and are safe for use in humans," Specter wrote in an April 21 letter to the president.

Under existing policy, federal funds for HESC research are available only for a limited number of cell lines established before August 9, 2001. Of some 78 stem cell lines initially identified as meeting the eligibility criteria, only 11 lines are presently available for researchers, Specter noted. Many scientists and politicians have argued that this number inhibits meaningful research. And because the currently qualified stem cell lines have been grown using mouse feeder cells, there ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Ted Agres

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development